Action of solamargine on human lung cancer cells - enhancement of the susceptibility of cancer cells to TNFs

被引:79
|
作者
Liu, LF
Liang, CH
Shiu, LY
Lin, WL
Lin, CC
Kuo, KW
机构
[1] I Shou Univ, Dept Med Radiat Technol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Sch Med, Dept Biochem, Kaohsiung 807, Taiwan
关键词
solamargine; drug resistance; lung cancer; apoptosis;
D O I
10.1016/j.febslet.2004.09.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solamargine (SM), isolated from Solanum incanum herb, displayed a superior cytotoxicity in four human lung cancer cell lines. The half-inhibitory concentrations (IC50), of the cell viability assay for H441, H520, H661 and H69 cells were 3, 6.7, 7.2 and 5.8 muM, respectively. SM-induced apoptosis of these cells by PS externalization in a dose-dependent manner and increased sub-G, fraction were observed. Quenching of the expression of tumor necrosis factor receptors (TNFRs) during the progress of human lung carcinogenesis has been previously reported. SM may induce cell apoptosis via modulating the expression of TNFRs and their subsequent TRADD/FADD signal cascades. Subsequently, SM treatment increased the binding activities of TNF-alpha and TNF-beta to the lung cancers, and the intrinsic TNFs-resistant cancer cells became susceptible to TNF-alpha and -beta. In addition, SM caused release of cytochrome c, downregulation of anti-apoptotic Bcl-2 and BCI-x(L), increase of caspase-3 activity, and DNA fragmentation. Thus, SM could modulate the expressions of TNFRs and Bcl-2, and might be a potential anticancer agent for TNFs and Bcl-2 related resistance of human lung cancer cells. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [21] Antitumor activity of a novel (-)-antofine analog in human lung cancer cells and paclitaxel-resistant lung cancer cells
    Song, Jayoung
    Bae, Song Yi
    Shin, Yoonho
    Kim, Won Kyung
    Oh, Jedo
    Choi, Tae Joon
    Jeong, Eun Ju
    Park, So Hyun
    Jang, Eun Jeong
    Kang, Ji In
    Park, Hyen Joo
    Hong, Ji-Young
    Chung, Hwa-Jin
    Kwon, Yongseok
    Kim, Sanghee
    Lee, Sang Kook
    CANCER RESEARCH, 2014, 74 (19)
  • [22] The characteristics of human NKT cells in lung cancer - CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients
    Konishi, J
    Yamazaki, K
    Yokouchi, H
    Shinagawa, N
    Iwabuchi, K
    Nishimura, M
    HUMAN IMMUNOLOGY, 2004, 65 (11) : 1377 - 1388
  • [23] Drug susceptibility testing of circulating lung cancer cells for personalized treatment
    Ajay Balakrishnan
    Antony George Francis Thottian
    K. Govind Babu
    Prashant Kumar
    Medical Oncology, 40
  • [24] Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells
    Fan, Teresa W. M.
    Bandura, Laura L.
    Higashi, Richard M.
    Lane, Andrew N.
    METABOLOMICS, 2005, 1 (04) : 325 - 339
  • [25] Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells
    Teresa W. M. Fan
    Laura L. Bandura
    Richard M. Higashi
    Andrew N. Lane
    Metabolomics, 2005, 1 : 325 - 339
  • [26] Drug susceptibility testing of circulating lung cancer cells for personalized treatment
    Balakrishnan, Ajay
    Thottian, Antony George Francis
    Babu, K. Govind
    Kumar, Prashant
    MEDICAL ONCOLOGY, 2022, 40 (01)
  • [27] Hesperetin Enhances Radiotherapy of Human Lung Cancer Cells
    Fam, A.
    Ngwa, W.
    Makrigiorgos, G.
    Yasmin-Karim, S.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [28] CLONING OF HUMAN-LUNG CANCER-CELLS
    WALLS, GA
    TWENTYMAN, PR
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 505 - 513
  • [29] Induction of apoptosis in human lung cancer cells by curcumin
    Pillai, GR
    Srivastava, AS
    Hassanein, TI
    Chauhan, DP
    Carrier, E
    CANCER LETTERS, 2004, 208 (02) : 163 - 170
  • [30] AhR function in human lung cancer cells.
    Jimma, Yoko
    Hakata, Shuko
    Habano, Wataru
    Ozawa, Shogo
    Terashima, Jun
    CANCER SCIENCE, 2018, 109 : 978 - 978